Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center.
Identifieur interne : 000552 ( Ncbi/Merge ); précédent : 000551; suivant : 000553Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center.
Auteurs : Fengbo Zhang [République populaire de Chine] ; Qiang Shao ; Thomas R W. Herrmann ; Ye Tian ; Yuhai ZhangSource :
- Urology [ 1527-9995 ] ; 2012.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical : Thulium.
- therapy : Prostatic Hyperplasia.
- Aged, Aged, 80 and over, Electrocoagulation, Female, Humans, Lasers, Solid-State, Low-Level Light Therapy, Male, Middle Aged, Prospective Studies, Quality of Life, Treatment Outcome.
Abstract
To compare the clinical outcomes between thulium laser transurethral enucleation of the prostate (ThuLEP) (70 W) and holmium laser transurethral enucleation of the prostate (HoLEP) (90 W) in a prospective randomized trial with 18 months of follow-up. Both ThuLEP and HoLEP effectively relieve the obstructive symptoms due to benign prostatic hyperplasia (BPH).
DOI: 10.1016/j.urology.2011.12.018
PubMed: 22342411
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000383
- to stream PubMed, to step Curation: 000383
- to stream PubMed, to step Checkpoint: 000383
Links to Exploration step
pubmed:22342411Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center.</title>
<author><name sortKey="Zhang, Fengbo" sort="Zhang, Fengbo" uniqKey="Zhang F" first="Fengbo" last="Zhang">Fengbo Zhang</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shao, Qiang" sort="Shao, Qiang" uniqKey="Shao Q" first="Qiang" last="Shao">Qiang Shao</name>
</author>
<author><name sortKey="Herrmann, Thomas R W" sort="Herrmann, Thomas R W" uniqKey="Herrmann T" first="Thomas R W" last="Herrmann">Thomas R W. Herrmann</name>
</author>
<author><name sortKey="Tian, Ye" sort="Tian, Ye" uniqKey="Tian Y" first="Ye" last="Tian">Ye Tian</name>
</author>
<author><name sortKey="Zhang, Yuhai" sort="Zhang, Yuhai" uniqKey="Zhang Y" first="Yuhai" last="Zhang">Yuhai Zhang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="doi">10.1016/j.urology.2011.12.018</idno>
<idno type="RBID">pubmed:22342411</idno>
<idno type="pmid">22342411</idno>
<idno type="wicri:Area/PubMed/Corpus">000383</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000383</idno>
<idno type="wicri:Area/PubMed/Curation">000383</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000383</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000383</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000383</idno>
<idno type="wicri:Area/Ncbi/Merge">000552</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center.</title>
<author><name sortKey="Zhang, Fengbo" sort="Zhang, Fengbo" uniqKey="Zhang F" first="Fengbo" last="Zhang">Fengbo Zhang</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shao, Qiang" sort="Shao, Qiang" uniqKey="Shao Q" first="Qiang" last="Shao">Qiang Shao</name>
</author>
<author><name sortKey="Herrmann, Thomas R W" sort="Herrmann, Thomas R W" uniqKey="Herrmann T" first="Thomas R W" last="Herrmann">Thomas R W. Herrmann</name>
</author>
<author><name sortKey="Tian, Ye" sort="Tian, Ye" uniqKey="Tian Y" first="Ye" last="Tian">Ye Tian</name>
</author>
<author><name sortKey="Zhang, Yuhai" sort="Zhang, Yuhai" uniqKey="Zhang Y" first="Yuhai" last="Zhang">Yuhai Zhang</name>
</author>
</analytic>
<series><title level="j">Urology</title>
<idno type="eISSN">1527-9995</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Electrocoagulation</term>
<term>Female</term>
<term>Humans</term>
<term>Lasers, Solid-State</term>
<term>Low-Level Light Therapy</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Prostatic Hyperplasia (therapy)</term>
<term>Quality of Life</term>
<term>Thulium</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hyperplasie de la prostate ()</term>
<term>Lasers à solide</term>
<term>Mâle</term>
<term>Photothérapie de faible intensité</term>
<term>Qualité de vie</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Thulium</term>
<term>Électrocoagulation</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Thulium</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Prostatic Hyperplasia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Electrocoagulation</term>
<term>Female</term>
<term>Humans</term>
<term>Lasers, Solid-State</term>
<term>Low-Level Light Therapy</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Quality of Life</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hyperplasie de la prostate</term>
<term>Lasers à solide</term>
<term>Mâle</term>
<term>Photothérapie de faible intensité</term>
<term>Qualité de vie</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Thulium</term>
<term>Électrocoagulation</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To compare the clinical outcomes between thulium laser transurethral enucleation of the prostate (ThuLEP) (70 W) and holmium laser transurethral enucleation of the prostate (HoLEP) (90 W) in a prospective randomized trial with 18 months of follow-up. Both ThuLEP and HoLEP effectively relieve the obstructive symptoms due to benign prostatic hyperplasia (BPH).</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">22342411</PMID>
<DateCreated><Year>2012</Year>
<Month>04</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>07</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1527-9995</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>79</Volume>
<Issue>4</Issue>
<PubDate><Year>2012</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Urology</Title>
<ISOAbbreviation>Urology</ISOAbbreviation>
</Journal>
<ArticleTitle>Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center.</ArticleTitle>
<Pagination><MedlinePgn>869-74</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.urology.2011.12.018</ELocationID>
<Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the clinical outcomes between thulium laser transurethral enucleation of the prostate (ThuLEP) (70 W) and holmium laser transurethral enucleation of the prostate (HoLEP) (90 W) in a prospective randomized trial with 18 months of follow-up. Both ThuLEP and HoLEP effectively relieve the obstructive symptoms due to benign prostatic hyperplasia (BPH).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A total of 133 consecutive patients with BPH were randomized to either ThuLEP (n = 71) or HoLEP (n = 62). An energy setting of 70 W and 90 W was used for the thulium and holmium laser in the enucleation procedure, respectively. The mushroom technique was used to fragment the enucleated lobes with the resection loop. The preoperative and postoperative parameters were compared.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">ThuLEP required a longer operation time (72.4 vs 61.5 minutes, P = .034) but resulted in less blood loss than HoLEP (130.0 vs 166.6 mL, P = .045). The catheterization time was comparable. At 18 months, the lower urinary tract symptom indexes were improved significantly in both groups compared with the baseline values. The International Prostate Symptom Score decreased to 5.2 in the ThuLEP group and 6.2 in the HoLEP group. The quality of life score and peak urinary flow rate were similar between the 2 groups (1.3 vs 1.2 and 23.4 vs 24.2 mL/s) and the postvoid residual urine volume decreased by 82.50% and 81.73% in the ThuLEP and HoLEP groups, respectively. The mean prostate-specific antigen decrease after HoLEP and ThuLEP was 30.43% and 43.36%, respectively. No urethral or bladder neck stricture were found in either group.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Both ThuLEP (70 W) and HoLEP (90 W) relieve lower urinary tract symptoms equally with high efficacy and safety. ThuLEP was statistically superior to HoLEP in blood loss and inferior to HoLEP in operation time, although the differences were clinically negligible. The mushroom technique could be adequate, without an additional mechanical tissue morcellator.</AbstractText>
<CopyrightInformation>Copyright © 2012 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Fengbo</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shao</LastName>
<ForeName>Qiang</ForeName>
<Initials>Q</Initials>
</Author>
<Author ValidYN="Y"><LastName>Herrmann</LastName>
<ForeName>Thomas R W</ForeName>
<Initials>TR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tian</LastName>
<ForeName>Ye</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Yuhai</ForeName>
<Initials>Y</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>02</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Urology</MedlineTA>
<NlmUniqueID>0366151</NlmUniqueID>
<ISSNLinking>0090-4295</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>8RKC5ATI4P</RegistryNumber>
<NameOfSubstance UI="D013932">Thulium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Urol. 2013 Feb;189(2):615-6</RefSource>
<PMID Version="1">23312184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>J Urol. 2013 Feb;189(2):614-5</RefSource>
<PMID Version="1">23312183</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004564">Electrocoagulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D053844">Lasers, Solid-State</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D028022">Low-Level Light Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013932">Thulium</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year>
<Month>9</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2011</Year>
<Month>11</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2011</Year>
<Month>12</Month>
<Day>9</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2012</Year>
<Month>2</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>2</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>2</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>7</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pii">S0090-4295(11)02756-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.urology.2011.12.018</ArticleId>
<ArticleId IdType="pubmed">22342411</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<settlement><li>Pékin</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Herrmann, Thomas R W" sort="Herrmann, Thomas R W" uniqKey="Herrmann T" first="Thomas R W" last="Herrmann">Thomas R W. Herrmann</name>
<name sortKey="Shao, Qiang" sort="Shao, Qiang" uniqKey="Shao Q" first="Qiang" last="Shao">Qiang Shao</name>
<name sortKey="Tian, Ye" sort="Tian, Ye" uniqKey="Tian Y" first="Ye" last="Tian">Ye Tian</name>
<name sortKey="Zhang, Yuhai" sort="Zhang, Yuhai" uniqKey="Zhang Y" first="Yuhai" last="Zhang">Yuhai Zhang</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Zhang, Fengbo" sort="Zhang, Fengbo" uniqKey="Zhang F" first="Fengbo" last="Zhang">Fengbo Zhang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000552 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000552 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Terre |area= ThuliumV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:22342411 |texte= Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:22342411" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a ThuliumV1
![]() | This area was generated with Dilib version V0.6.21. | ![]() |